Kluss, J. H., Mazza, M. C., Li, Y., Manzoni, C., Lewis, P. A., Cookson, M. R., & Mamais, A. (2021). Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo. Mol Neurodegener.

Kluss, Jillian H., Melissa Conti Mazza, Yan Li, Claudia Manzoni, Patrick A. Lewis, Mark R. Cookson, and Adamantios Mamais. "Preclinical Modeling of Chronic Inhibition of the Parkinson’s Disease Associated Kinase LRRK2 Reveals Altered Function of the Endolysosomal System in Vivo." Mol Neurodegener 2021.

Kluss, Jillian H., et al. "Preclinical Modeling of Chronic Inhibition of the Parkinson’s Disease Associated Kinase LRRK2 Reveals Altered Function of the Endolysosomal System in Vivo." Mol Neurodegener 2021.